MPM
BEAT

Meritage Portfolio Management’s BioTelemetry, Inc. BEAT Stock Holding History

Meritage Portfolio Management’s Portfolio BEAT Stock Details BEAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-157,273
Closed -$9.85M – 237
2019
Q1 		$9.85M Buy
+157,273
New +$10.8M 1% 21

Other funds holding BEAT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Meritage Portfolio Management's BEAT Position: Q2 2019 in Review

Meritage Portfolio Management sold out of BioTelemetry, Inc. (BEAT) in Q2 2019, closing a stake of 157,273 shares — an estimated $9.85M sold.

Meritage Portfolio Management first reported a position in BEAT in Q1 2019 and held it in 1 quarter. The position peaked at $9.85M in Q1 2019. 251 funds tracked by Wall St. Rank hold BEAT as of Q2 2019.

  • Meritage Portfolio Management reported no remaining BioTelemetry, Inc. position as of Q2 2019 after selling out during the quarter.
  • Meritage Portfolio Management sold 157,273 BioTelemetry, Inc. shares in Q2 2019, an estimated $9.85M.
  • Meritage Portfolio Management first reported a position in BioTelemetry, Inc. in Q1 2019 and held it in 1 quarter.
  • Meritage Portfolio Management's BioTelemetry, Inc. position peaked at $9.85M in Q1 2019.
  • 251 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q2 2019.

Based on Meritage Portfolio Management's 13F filing for Q2 2019, filed 30 Jul 2019.